NCT04621188 2025-09-24Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)Intergroupe Francophone de Cancerologie ThoraciquePhase 2 Active not recruiting54 enrolled